TipRanks
Go Ultimate55% OFF

Colgate-Palmolive (CPA) AI Stock Analysis

DE:CPA

Colgate-Palmolive

(XETRA:CPA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Global Brand and Market-Share StrengthGlobal share gains across core oral-care categories indicate strong brand relevance and distribution execution. Because these products are frequently repurchased, sustained share improvement can support recurring volume, pricing power, and durable competitive positioning over the coming quarters.
Negative Factors
Very High Leverage and Thin EquityThe highly leveraged capital structure leaves limited equity support relative to debt and reduces financial flexibility. Greater sensitivity to refinancing costs or operating weakness could constrain investment, shareholder returns, and the company's ability to absorb a prolonged downturn.

Colgate-Palmolive (CPA) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%DE:CPA+33.61%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 75.96B
Dividend Yield
2.12%
Average Volume (3M)
427
Price to Earnings (P/E)
37.0
Beta (1Y)
0.20
Revenue Growth
0.67%
EPS Growth
-31.77%
Country
Germany
Employees
33,600
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

Colgate-Palmolive Business Overview & Revenue Model

Company Description

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and...

Colgate-Palmolive Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q3-2026)|% Change Since:4.06%|Next Earnings Date:Jan 21, 2027
Earnings Call SentimentPositive

The call was broadly optimistic. Colgate-Palmolive reported solid organic sales, EPS, cash flow, gross margin, market share, and regional performance, supported by productivity, pricing, premium innovation, advertising, and AI investments. The main challenges were elevated commodity and logistics costs, foreign exchange pressure, sluggish developed-market categories, the ongoing U.S. turnaround, Mexico-specific issues, and weakness in parts of China and Hill's. Management emphasized that productivity and revenue growth management are currently offsetting much of the cost pressure and expressed confidence in the company's global model and long-term growth opportunities.

Positive Updates

Broad-Based Top- and Bottom-Line Growth
Colgate-Palmolive delivered another quarter of solid top- and bottom-line growth, with organic sales growth across all four categories and four of five divisions. Base business EPS came in ahead of expectations.

Negative Updates

Elevated and Volatile Cost Environment
Management expects the elevated cost environment to continue through the fourth quarter and into early next year. Total cost inflation remains roughly in the original range of $300± million, with Q4 expected to have the highest level of commodity inflation on a year-on-year basis.

Company Guidance

Colgate-Palmolive said it expects the cost environment to continue through the fourth quarter and into the early part of next year, with tariffs peaking in the fourth quarter, underlying cost commodity pressure remaining elevated in Q4 and the near term, Q4 having “probably the highest level of commodity inflation on a year-on-year basis,” and Q4 logistics costs being the highest logistics cost quarter of the year, both in dollars and as a percent of sales; full-year gross profit margin is expected to expand year-on-year, up from roughly flat previously, while cost inflation remains roughly in the original range of $300± million. Global category growth is expected to continue at 1.5%-3%, with emerging markets in the 3%-5% range and developed markets in the 1.5%-2% range, while another comment cited developed-market growth in the “1.5 to more or less 2.5 growth rate.” The company said it expects more pricing globally, with pricing in developed markets likely to come through new innovation and list prices more likely in emerging markets, and will not share 2027 guidance until the first quarter of next year.

Colgate-Palmolive Risk Analysis

Colgate-Palmolive disclosed 19 risk factors in its most recent earnings report. Colgate-Palmolive reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Colgate-Palmolive Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:CPA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CHDCHD78Outperform$25.44B32.8918.21%1.14%1.70%2.07%
KMBKMB78Outperform$35.90B18.36122.57%4.72%-12.19%-19.22%
PGPG72Outperform$374.48B23.9429.55%2.68%3.52%-3.74%
KVUEKVUE70Outperform$37.09B21.9416.06%5.40%3.50%17.82%
ULUL64Neutral$140.47B13.7058.26%3.41%-17.45%8.84%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%

* Consumer Defensive Sector Average

Performance Comparison

-10%0%10%20%30%DE:CPACHDKMBPGULKVUEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:CPA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:CPAColgate-palmolive Company86.1622.0134.31%
CHDChurch & Dwight Company107.2322.0525.89%
KMBKimberly Clark107.9410.6510.95%
PGProcter & Gamble Company161.5717.7212.32%
ULUnilever plc65.262.433.87%
KVUEKenvue, Inc.19.314.0926.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.